How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists

Pediatric Nephrology

Volumn 20, Issue 6, 2005, Pages 791-797

  Woroniecki, Robert P ^a   Flynn, Joseph T ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adolescents; Children; Clinical guidelines; Hypertension; Pharmacotherapy

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; NEPHROLOGY; NORTH AMERICA; OSCILLOMETRY; PATIENT CARE; PEDIATRICS; PRIORITY JOURNAL; PROTEINURIA; SPHYGMOMANOMETER;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CANADA; CHILD; GOALS; HUMANS; HYPERTENSION; KIDNEY FAILURE; NEPHROLOGY; PEDIATRICS; PROFESSIONAL PRACTICE; PROTEINURIA; QUESTIONNAIRES; UNITED STATES;

EID: 18644372039     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1804-6     Document Type: Article

References (24)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967) Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 202:1028-1034
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213:1143-1152
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289:2560-2572 10.1001/jama.289.19.2560
4. Bakris GL, Williams M, Dworkin L, Elliot WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J (2000) Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 36:646-661 1:STN:280:DC%2BD3cvjsFSqsw%3D%3D
5. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland (1987) Report of the second task force on blood pressure control in children - 1987. Pediatrics 79:1-25 3797155
6. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the national high blood pressure education program. Pediatrics 98:649-658 8885941
7. Sorof JM, Portman RJ (2001) Ambulatory blood pressure measurements. Curr Opin Pediatr 13:133-137
8. Flynn JT (2001) What's new in pediatric hypertension? Curr Hypertens Rep 3:503-510
9. Sakarcan A, Tenney F, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR. (2001) The pharmacokinetics of irbesartan in hypertensive children and adolescents. J Clin Pharmacol 41:742-749
10. Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S; Enalapril Pediatric Hypertension Collaborative Study Group (2002) A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 42:870-880 10.1177/009127002401102786
11. Trachtman H, Frank R, Mahan JD, Portman R, Restaino I, Matoo TJ, Tou C, Kilbaner M (2003) Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol 18:548-553
12. Flynn JT (2003) Successes and shortcomings of the FDA modernization act. Am J Hypertens 16:889-891
13. O'Brien E (2003) Demise of the mercury sphygmomanometer and the dawning of a new era in blood pressure measurement. Blood Press Monit 8:19-21 10.1097/00126097-200302000-00004
14. Kaufmann MA, Pargger H, Drop LJ (1996) Oscillometric blood pressure measurements by different devices are not interchangeable. Anesth Analg 82:377-381
15. Butani L, Morgenstern BZ (2003) Are pitfalls of oscillometric blood pressure measurements preventable in children? Pediatr Nephrol 18:313-318
16. Canzanello VJ, Jensen PL, Schwartz GL (2001) Are aneroid sphygmomanometers accurate in hospital and clinic settings? Arch Intern Med 161:729-731 10.1001/archinte.161.5.729
17. Lurbe E, Sorof JM, Daniels SR (2004) Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 144:7-16
18. Bald M, Hoyer PF (2001) Measurement of blood pressure at home: Survey among pediatric nephrologists. Pediatr Nephrol 16:1058-1062
19. Mansoor GA (2003) A practical approach to persistent elevation of blood pressure in the hypertension clinic. Blood Press Monit 8:97-100
20. Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, O'Brien ET; Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators (2004) Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: A randomized controlled trial. JAMA 291:955-964
21. Wuhl E, Hadtstein C, Mehls O, Schaefer F; Escape Trial Group (2004) Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 55:492-497 10.1203/ 01.PDR.0000106863.90996.76
22. Soergel M, Verho M, Wuhl E, Gellermann J, Teichert L, Scharer K (2000) Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatr Nephrol 15:113-118
23. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555-576
24. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997 12479763